Senesco Technologies, Inc. (SNT) Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial
6/19/2013 9:56:26 AM
More...
|
Vaxart, Inc.’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans
6/19/2013 9:47:53 AM
More...
|
University of California, Los Angeles (UCLA) Presents Data on MediciNova, Inc.'s MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence
6/19/2013 9:40:22 AM
More...
|
Allied's Herpes Vaccine Progresses to Phase 1 Clinical Trial
6/19/2013 8:56:14 AM
More...
|
Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients
6/18/2013 10:53:14 AM
More...
|
PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases
6/18/2013 9:30:58 AM
More...
|
DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
6/18/2013 9:24:19 AM
More...
|
AbbVie (ABBV) Presents Preliminary Results From Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6/17/2013 11:21:17 AM
More...
|
Array BioPharma, Inc. (ARRY) Announces Positive Interim Results From Combination Trial of ARRY-520 With Kyprolis at the 2013 European Hematology Association Congress
6/17/2013 11:10:55 AM
More...
|
Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting
6/17/2013 10:54:22 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients With Hypoparathyroidism
6/17/2013 9:27:46 AM
More...
|
Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma
6/17/2013 9:17:03 AM
More...
|
Cell Therapeutics, Inc. (CTIC) Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients With Myelofibrosis
6/17/2013 8:56:24 AM
More...
|
Nanobiotix Receives Approval From ANSM to Start New Clinical Trial With Lead Product NBTXR3
6/13/2013 8:53:47 AM
More...
|
NW Bio Has Initiated Its DCVax®-Direct Phase I/II Trial for All Solid Tumor Cancers
6/13/2013 2:38:55 PM
More...
|
|